People taking the popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions, a new federal study finds. The research, funded by the National Institutes of Health, was published Friday and comes as European and U.S. regulators look into anecdotal reports that people taking the drug, semaglutide, had thoughts of self-harm. NIH and Case Western Reserve University researchers analyzed electronic medical records from more than 1.8 million patients prescribed semaglutide or another drug to treat obesity or diabetes between 2017 and 2022.